Pharmaceuticals based on papillomaviruses

Details Pharmaceuticals based on papillomaviruses Pharmaceuticals based on papillomaviruses

A - Human Necessities

61

K

A61K 39/12 (2006.01) A61K 39/00 (2006.01) C07K 14/025 (2006.01)

Patent

CA 2158554

The invention provides pharmaceutical formulations for the prophylaxis of papillomavirus tumours or lesions. Formulations may be selected from the group consisting of (i) a formulation which comprises a papillomavirus (PV) L2 protein or prophylactically effective fragment thereof and an aluminium compound; (ii) a formulation which comprises a bovine papillomavirus (BPV) L2 protein or prophylactically effective fragment thereof and an aluminium compound; (iii) a formulation which comprises a BPV-4 L2 protein or prophylactically effective fragment thereof and an aluminium compound; (iv) a formulation which comprises a BPV-4 protein or prophylactically effective fragment thereof and an adjuvant; (v) a formulation which comprises a BPV-4 L2 protein or prophylactically effective fragment thereof and an adjuvant; and (vi) a formulation which comprises a BPV-4 protein or prophylactically effective fragment thereof and an aluminium compound.

Affiliated with

Also associated with

Rating

Pharmaceuticals based on papillomaviruses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceuticals based on papillomaviruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceuticals based on papillomaviruses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1749602